- Report
- April 2024
- 1800 Pages
Global
From €3858EUR$3,995USD£3,302GBP
- Report
- January 2024
- 200 Pages
Global
From €4829EUR$5,000USD£4,132GBP
- Report
- March 2024
- 183 Pages
Global
From €3259EUR$3,374USD£2,789GBP
€3621EUR$3,749USD£3,099GBP
- Report
- January 2024
- 200 Pages
Global
From €4829EUR$5,000USD£4,132GBP
- Report
- November 2023
- 190 Pages
Global
From €4732EUR$4,900USD£4,050GBP
- Report
- October 2023
- 171 Pages
Global
From €4732EUR$4,900USD£4,050GBP
- Report
- November 2019
- 169 Pages
Global
From €1328EUR$1,375USD£1,136GBP
€2656EUR$2,750USD£2,273GBP
-
Journal - April 2024
- 66 Pages
Global
From €410EUR$425USD£351GBP
- Book
- April 2013
- 294 Pages
- Book
- July 2012
- 448 Pages
Pediatric Oncology is a branch of medicine that focuses on the diagnosis, treatment, and prevention of cancer in children. It is a specialized field of medicine that requires a multidisciplinary approach, involving pediatricians, oncologists, surgeons, radiation oncologists, pathologists, and other healthcare professionals. Treatment plans are tailored to the individual child and may include chemotherapy, radiation therapy, surgery, and other treatments.
Pediatric Oncology is a rapidly evolving field, with new treatments and technologies being developed to improve outcomes for children with cancer. Research is ongoing to better understand the causes of childhood cancer and to develop more effective treatments.
Companies in the Pediatric Oncology market include Novartis, Pfizer, Merck, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more
